Real-World Outcomes of Multiple Myeloma: Retrospective Analysis of the Czech Registry of Monoclonal Gammopathies

The Registry of Monoclonal Gammopathies (RMG) collects long-term data on patients with hematological malignancies and is one of the largest registries of its kind in Europe. This non-interventional, observational study analyzed real-world data from 2446 Czech patients from the RMG to provide insights into real-world treatment outcomes in patients with multiple myeloma.

Source: Clinical Lymphoma, Myeloma and Leukemia - April 16, 2018 Category: Hematology Authors: Roman H ájek, Jiri Jarkovsky, Vladimír Maisnar, Ludek Pour, Ivan Špička, Jiri Minařík, Evžen Gregora, Petr Kessler, Michal Sýkora, Hana Fraňková, Marco Campioni, Lucy DeCosta, Maarten Treur, Sebastian Gonzalez-McQuire, Walter Bouwmeester Tags: Original Study Source Type: research